mitomycin has been researched along with Conjunctival Neoplasms in 137 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Conjunctival Neoplasms: Tumors or cancer of the CONJUNCTIVA.
Excerpt | Relevance | Reference |
---|---|---|
"Local chemotherapy with mitomycin C is a useful option in the treatment of malignant melanomas of the conjunctiva associated with PAM if the tumor stage is pT3 or less." | 9.10 | [Management of conjunctival malignant melanoma associated with primary acquired melanosis (PAM) using 0.02% mitomycin C eyedrops]. ( Conway, RM; Groh, MJ; Holbach, LM; Kühnel, B; Naumann, GO, 2003) |
"Topical mitomycin chemotherapy was found to induce regression of conjunctival melanoma and primary acquired melanosis with atypia." | 9.09 | Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations. ( Demirci, H; Finger, PT; McCormick, SA, 2000) |
"To evaluate topical mitomycin C (MMC) chemotherapy in the treatment of conjunctival melanoma and primary acquired melanosis with atypia." | 9.08 | Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia. ( Czechonska, G; Finger, PT; Liarikos, S, 1998) |
"To report a case of a large conjunctival melanoma (CM) successfully treated with surgical resection and pre- and postoperative topical mitomycin C (MMC)." | 8.02 | Extensive conjunctival melanoma successfully treated with surgical resection and pre- and postoperative topical mitomycin C. ( Giansanti, F; Mazzini, C; Nicolosi, C; Pieretti, G; Vicini, G; Virgili, G, 2021) |
"To describe the clinical and histological resolution of a case of an inexcisable conjunctival melanoma using topical interferon alpha 2b (INFα2b) in a patient with mitomycin C (MMC) intolerance." | 7.88 | Resolution of conjunctival melanoma with topical interferon alpha 2b in a patient with mitomycin C intolerance. ( Chaparro Tapias, TA; Coy Villamil, H; Díaz Díaz, AL; Sánchez España, JC; Secondi, R, 2018) |
"To report the long-term complications and rate of local recurrence in a cohort of patients with histopathologically confirmed conjunctival melanoma (CM) treated with adjuvant topical mitomycin C (MMC)." | 7.77 | Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mitomycin C: complications and recurrences. ( Ditta, LC; Shildkrot, Y; Wilson, MW, 2011) |
"Sodium butyrate and trichostatin induced cell death in melanoma cells, comparable with mitomycin C, with minimal effect on Tenon capsule fibroblasts." | 7.75 | In vitro effects of histone deacetylase inhibitors and mitomycin C on tenon capsule fibroblasts and conjunctival melanoma cells. ( Conway, RM; Cunneen, TS; Madigan, MC, 2009) |
"To describe a case of recurrent, advanced conjunctival papillomatosis, treated by oral cimetidine (CIM) combined with secondary surgical intervention and an application of intraoperative mitomycin C." | 7.73 | Oral cimetidine adjuvant therapy for recalcitrant, diffuse conjunctival papillomatosis. ( Chang, SW; Huang, ZL, 2006) |
"Conjunctival melanoma and PAM responded to mitomycin 0." | 7.73 | Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience. ( Finger, PT; Kurli, M, 2005) |
"To present the clinical and histologic findings of a patient in whom intumescent cataract developed after successful topical mitomycin-C (MMC) chemotherapy for conjunctival melanoma originating from primary acquired conjunctival melanosis (PAM) with atypia." | 7.72 | Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma. ( Horvat, R; Lukas, JR; Sacu, S; Ségur-Eltz, N; Zehetmayer, M, 2003) |
"To describe the use of postoperative topical mitomycin C (MMC) in the treatment of recurrent conjunctival papilloma." | 7.71 | The use of postoperative topical mitomycin C in the treatment of recurrent conjunctival papilloma. ( Chan, NR; Chi, SC; Lam, DS; Yeung, EF; Yuen, HK, 2002) |
" In this study we aimed to evaluate the effectivity of postsurgical chemotherapy of conjunctival squamous cell carcinoma in situ (CIN) with mitomycin C eyedrops." | 7.71 | [Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control]. ( Böcking, A; Cartsburg, O; Kersten, A; Nadjari, B; Pomjanski, N; Sundmacher, R, 2001) |
"Excision with application of mitomycin C was successful in managing a case of squamous papillomatosis that was resistant to traditional therapy." | 7.70 | Treatment of recurrent conjunctival papillomatosis with mitomycin C. ( Hamming, NA; Hawkins, AS; Rubenstein, JB; Yu, J, 1999) |
"Since 1995 we have used Mitomycin C additionally in the treatment of conjunctival melanoma and primary acquired melanosis." | 7.70 | [Mitomycin C in treatment of conjunctival melanoma and primary acquired melanosis]. ( Lommatzsch, PK; Werschnik, C, 1998) |
"The lesion was diagnosed as invasive squamous cell carcinoma on histopathology and topical 0." | 5.37 | Periocular allergic contact dermatitis following topical Mitomycin C eye drop application. ( Cavdar, M; Cumurcu, T; Sener, S, 2011) |
"We observed euploid DNA-polyploidy and cytomorphological changes in all patients (19/19)." | 5.31 | Topical mitomycin C and radiation induce conjunctival DNA-polyploidy. ( Böcking, A; Cartsburg, O; Hillenkamp, J; Kallen, C; Pomjanski, N; Sundmacher, R, 2001) |
" If Mitomycin is used in that low dosage and in that special application as shown, it could be a very efficient therapy with less complications." | 5.31 | [The treatment of a primary acquired melanosis of the conjunctiva with atypia by low dose of Mitomycin C 0.02 % - case report with follow up of 2 years]. ( Klaehsen, D; Maier, M; Merté, RL; Schmidt, M; Schmidt, T, 2001) |
"Local chemotherapy with mitomycin C is a useful option in the treatment of malignant melanomas of the conjunctiva associated with PAM if the tumor stage is pT3 or less." | 5.10 | [Management of conjunctival malignant melanoma associated with primary acquired melanosis (PAM) using 0.02% mitomycin C eyedrops]. ( Conway, RM; Groh, MJ; Holbach, LM; Kühnel, B; Naumann, GO, 2003) |
"Topical mitomycin chemotherapy was found to induce regression of conjunctival melanoma and primary acquired melanosis with atypia." | 5.09 | Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations. ( Demirci, H; Finger, PT; McCormick, SA, 2000) |
"To evaluate topical mitomycin C (MMC) chemotherapy in the treatment of conjunctival melanoma and primary acquired melanosis with atypia." | 5.08 | Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia. ( Czechonska, G; Finger, PT; Liarikos, S, 1998) |
"We herein compare topical interferon alpha 2b (IFN-α2b) to topical mitomycin C (MMC) in the adjuvant management after excision of primary acquired melanosis with atypia (PAM) and melanoma of the conjunctiva/cornea (CM)." | 4.31 | Real-life data of adjuvant IFN-α2b and MMC in conjunctival melanocytic lesions. ( Auw-Haedrich, C; Boehringer, D; Jiang, J; Nuessle, S; Reinhard, T, 2023) |
"To report a case of a large conjunctival melanoma (CM) successfully treated with surgical resection and pre- and postoperative topical mitomycin C (MMC)." | 4.02 | Extensive conjunctival melanoma successfully treated with surgical resection and pre- and postoperative topical mitomycin C. ( Giansanti, F; Mazzini, C; Nicolosi, C; Pieretti, G; Vicini, G; Virgili, G, 2021) |
"To describe the clinical and histological resolution of a case of an inexcisable conjunctival melanoma using topical interferon alpha 2b (INFα2b) in a patient with mitomycin C (MMC) intolerance." | 3.88 | Resolution of conjunctival melanoma with topical interferon alpha 2b in a patient with mitomycin C intolerance. ( Chaparro Tapias, TA; Coy Villamil, H; Díaz Díaz, AL; Sánchez España, JC; Secondi, R, 2018) |
"The recommended treatment for conjunctival melanoma is surgical removal with adjunctive therapies such as cryotherapy or topical mitomycin-C." | 3.80 | [Treatment of conjunctival melanoma]. ( Baamonde Arbaiza, B; de la Roz Martín, P; Parra Rodríguez, T; Salazar Méndez, R, 2014) |
"To report the long-term complications and rate of local recurrence in a cohort of patients with histopathologically confirmed conjunctival melanoma (CM) treated with adjuvant topical mitomycin C (MMC)." | 3.77 | Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mitomycin C: complications and recurrences. ( Ditta, LC; Shildkrot, Y; Wilson, MW, 2011) |
"Persistent epitheliopathy, presumably resulting from limbal stem cell deficiency, is an uncommon complication of treatment of conjunctival malignant melanoma with surgical excision, cryotherapy, and mitomycin C." | 3.76 | Boston Ocular Surface Prosthesis for persistent epitheliopathy after treatment of conjunctival melanoma. ( Colby, KA; Grover, S; Jacobs, DS, 2010) |
"Sodium butyrate and trichostatin induced cell death in melanoma cells, comparable with mitomycin C, with minimal effect on Tenon capsule fibroblasts." | 3.75 | In vitro effects of histone deacetylase inhibitors and mitomycin C on tenon capsule fibroblasts and conjunctival melanoma cells. ( Conway, RM; Cunneen, TS; Madigan, MC, 2009) |
"Conjunctival melanoma and PAM responded to mitomycin 0." | 3.73 | Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience. ( Finger, PT; Kurli, M, 2005) |
"To describe a case of recurrent, advanced conjunctival papillomatosis, treated by oral cimetidine (CIM) combined with secondary surgical intervention and an application of intraoperative mitomycin C." | 3.73 | Oral cimetidine adjuvant therapy for recalcitrant, diffuse conjunctival papillomatosis. ( Chang, SW; Huang, ZL, 2006) |
"To present the clinical and histologic findings of a patient in whom intumescent cataract developed after successful topical mitomycin-C (MMC) chemotherapy for conjunctival melanoma originating from primary acquired conjunctival melanosis (PAM) with atypia." | 3.72 | Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma. ( Horvat, R; Lukas, JR; Sacu, S; Ségur-Eltz, N; Zehetmayer, M, 2003) |
"To describe the use of postoperative topical mitomycin C (MMC) in the treatment of recurrent conjunctival papilloma." | 3.71 | The use of postoperative topical mitomycin C in the treatment of recurrent conjunctival papilloma. ( Chan, NR; Chi, SC; Lam, DS; Yeung, EF; Yuen, HK, 2002) |
" In this study we aimed to evaluate the effectivity of postsurgical chemotherapy of conjunctival squamous cell carcinoma in situ (CIN) with mitomycin C eyedrops." | 3.71 | [Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control]. ( Böcking, A; Cartsburg, O; Kersten, A; Nadjari, B; Pomjanski, N; Sundmacher, R, 2001) |
"Since 1995 we have used Mitomycin C additionally in the treatment of conjunctival melanoma and primary acquired melanosis." | 3.70 | [Mitomycin C in treatment of conjunctival melanoma and primary acquired melanosis]. ( Lommatzsch, PK; Werschnik, C, 1998) |
"To describe the epithelial changes observed in the conjunctiva secondary to the use of topical mitomycin C (MMC) for treatment of primary acquired melanosis with atypia." | 3.70 | Cytologic changes in the conjunctiva mimicking malignancy after topical mitomycin C chemotherapy. ( Cuevas, K; Folberg, R; Mathers, WD; Salomão, DR; Sutphin, JE, 1999) |
"Excision with application of mitomycin C was successful in managing a case of squamous papillomatosis that was resistant to traditional therapy." | 3.70 | Treatment of recurrent conjunctival papillomatosis with mitomycin C. ( Hamming, NA; Hawkins, AS; Rubenstein, JB; Yu, J, 1999) |
" Regarding adverse effects, one or more mild adverse reaction occurred in 77% of patients managed with MMC and in 50% of patients managed with IFNα2b (p > 0." | 3.30 | Safety and efficacy of topical interferon alpha 2B and mitomycin C for localized conjunctival intraepithelial neoplasia: long-term report of their pharmacological safety and efficacy. ( Alvarado-Castillo, B; Garcia-Benavides, L; Gonzalez-Castillo, C; Navarro-Partida, J; Rosales-Gradilla, ME; Santa Cruz-Pavlovich, FJ; Vidal-Paredes, IA, 2023) |
"Mitomycin C has been shown in studies to be highly effective but has short-term and long-term side-effects that may be intolerable." | 2.49 | Topical chemotherapy for ocular surface squamous neoplasia. ( Karp, CL; Nanji, AA; Sayyad, FE, 2013) |
"Conjunctival melanoma is an exceedingly rare tumor in black patients." | 2.43 | Conjunctival melanoma arising from diffuse primary acquired melanosis in a young black woman. ( Colby, KA; Nagel, DS, 2005) |
"Conjunctival melanoma is extremely rare in children and has low rates of resolution." | 1.72 | Fluorescent in situ hybridization (FISH): A useful diagnostic tool for childhood conjunctival melanoma. ( María Moral, R; María Peiró, A; Monteagudo, C; Moreno, L; Muriel, J, 2022) |
"BACKGROUND Conjunctival squamous cell carcinoma is the most common non-pigmented malignancy of the ocular surface." | 1.56 | Clinical Management of Squamous Cell Carcinoma of the Conjunctiva. ( Bartz-Schmidt, KU; Bösmüller, HC; Bramkamp, M; Milla, J; Röck, D; Röck, T, 2020) |
"Squamous cell carcinoma is the most common malignant tumor of the bulbar conjunctiva." | 1.51 | [Management of squamous cell carcinoma of the conjunctiva in a young patient: Case report]. ( Abdou, T; Benhadouch, R; Dib, S, 2019) |
"The aim of the study is to evaluate the long-term clinical results of amniotic membrane transplantation (AMT) combined with mitomycin C (MMC) for reconstruction of conjunctival defects created during the excision of ocular surface squamous neoplasia (OSSN)." | 1.46 | Long-term outcome of amniotic membrane transplantation combined with mitomycin C for conjunctival reconstruction after ocular surface squamous neoplasia excision. ( Hanada, K; Miyokawa, N; Nishikawa, N; Yoshida, A, 2017) |
"Two of eight patients (25 %) with squamous cell carcinoma (SCC) had positive lateral margins." | 1.39 | Combined excision, cryotherapy, and intraoperative mitomycin C (EXCRIM) for localized intraepithelial and squamous cell carcinoma of the conjunctiva. ( Arvas, S; Pazarli, H; Sarici, AM, 2013) |
"He was diagnosed with conjunctival squamous cell carcinoma and treated with topical mitomycin C (MMC)." | 1.37 | Herpes keratitis in a patient undergoing treatment with topical mitomycin C. ( Amorese, L; Foster, S; Gonzalez-Gonzalez, LA; Shaikh, M; Siddique, SS, 2011) |
"The lesion was diagnosed as invasive squamous cell carcinoma on histopathology and topical 0." | 1.37 | Periocular allergic contact dermatitis following topical Mitomycin C eye drop application. ( Cavdar, M; Cumurcu, T; Sener, S, 2011) |
"05%) combined with MMC (0." | 1.33 | Topical cyclosporine-a combined with mitomycin C for conjunctival and corneal squamous cell carcinoma. ( Erbilen, E; Tunc, M, 2006) |
" If Mitomycin is used in that low dosage and in that special application as shown, it could be a very efficient therapy with less complications." | 1.31 | [The treatment of a primary acquired melanosis of the conjunctiva with atypia by low dose of Mitomycin C 0.02 % - case report with follow up of 2 years]. ( Klaehsen, D; Maier, M; Merté, RL; Schmidt, M; Schmidt, T, 2001) |
"We observed euploid DNA-polyploidy and cytomorphological changes in all patients (19/19)." | 1.31 | Topical mitomycin C and radiation induce conjunctival DNA-polyploidy. ( Böcking, A; Cartsburg, O; Hillenkamp, J; Kallen, C; Pomjanski, N; Sundmacher, R, 2001) |
"DNA cytometry showed nonaneuploidy in all of these." | 1.30 | Cytologic and DNA cytometric diagnosis and therapy monitoring of squamous cell carcinoma in situ and malignant melanoma of the cornea and conjunctiva. ( Böcking, A; Kersten, A; Krallmann, R; Motherby, H; Nadjari, B; Ross, B; Sundmacher, R, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 15 (10.95) | 18.2507 |
2000's | 63 (45.99) | 29.6817 |
2010's | 43 (31.39) | 24.3611 |
2020's | 16 (11.68) | 2.80 |
Authors | Studies |
---|---|
Witsberger, EM | 1 |
Dalvin, LA | 1 |
Patel, SV | 1 |
Moratal Peiro, B | 1 |
Calvo Garcia, R | 1 |
Soler Sanchis, I | 1 |
Mata Moret, L | 1 |
Cervera Taulet, E | 1 |
Kozma, K | 1 |
Dömötör, ZR | 1 |
Csutak, A | 1 |
Szabó, L | 1 |
Hegyi, P | 1 |
Erőss, B | 1 |
Helyes, Z | 1 |
Molnár, Z | 1 |
Dembrovszky, F | 1 |
Szalai, E | 1 |
Sammarco, MG | 2 |
Pagliara, MM | 2 |
Savino, G | 1 |
Giannuzzi, F | 1 |
Carlà, MM | 1 |
Caputo, CG | 1 |
Blasi, MA | 2 |
Nuessle, S | 1 |
Auw-Haedrich, C | 2 |
Jiang, J | 2 |
Boehringer, D | 1 |
Reinhard, T | 2 |
Böhringer, D | 1 |
Auw-Hädrich, C | 1 |
Maier, PC | 1 |
Barth, T | 1 |
Eter, N | 1 |
Fuest, M | 1 |
Geerling, G | 1 |
Heindl, LM | 1 |
Herwig-Carl, M | 1 |
Hintschich, C | 1 |
Hufendiek, K | 1 |
Kampik, D | 1 |
Lieb, W | 1 |
Meller, D | 2 |
Mueller, A | 1 |
Pfeiffer, N | 1 |
Rehak, M | 1 |
Schargus, M | 1 |
Seitz, B | 1 |
Spitzer, M | 1 |
Stahl, A | 1 |
Süsskind, D | 1 |
van Oterendorp, C | 1 |
Wagner, FM | 1 |
Westekemper, H | 4 |
Ziemssen, F | 1 |
Monroy, D | 1 |
Serrano, A | 1 |
Galor, A | 3 |
Karp, CL | 4 |
Alvarado-Castillo, B | 1 |
Santa Cruz-Pavlovich, FJ | 1 |
Gonzalez-Castillo, C | 1 |
Vidal-Paredes, IA | 1 |
Garcia-Benavides, L | 1 |
Rosales-Gradilla, ME | 1 |
Navarro-Partida, J | 1 |
Suman, S | 1 |
Kumar, A | 1 |
Röck, T | 1 |
Bartz-Schmidt, KU | 1 |
Bramkamp, M | 1 |
Milla, J | 1 |
Bösmüller, HC | 1 |
Röck, D | 1 |
Mazzini, C | 1 |
Pieretti, G | 1 |
Vicini, G | 1 |
Nicolosi, C | 1 |
Virgili, G | 1 |
Giansanti, F | 1 |
Manthey, A | 1 |
Bechrakis, N | 1 |
Soto, H | 1 |
Bowen, RC | 1 |
Raval, V | 1 |
Yeaney, G | 1 |
Singh, A | 1 |
Aboumourad, RJ | 1 |
María Moral, R | 1 |
Monteagudo, C | 1 |
Muriel, J | 1 |
Moreno, L | 1 |
María Peiró, A | 1 |
Minot, M | 1 |
Gonzalvez, M | 1 |
Denis, D | 1 |
David, T | 1 |
Parrozzani, R | 1 |
Frizziero, L | 1 |
Midena, E | 1 |
Scholz, SL | 1 |
Eckstein, A | 1 |
Dekowski, D | 1 |
Esser, J | 1 |
Steuhl, KP | 3 |
Kaimbo Wa Kaimbo, D | 1 |
Maceroni, M | 1 |
Singh, M | 1 |
Gautam, N | 1 |
Kaur, M | 1 |
Chaparro Tapias, TA | 1 |
Díaz Díaz, AL | 1 |
Secondi, R | 1 |
Coy Villamil, H | 1 |
Sánchez España, JC | 1 |
Polski, A | 1 |
Sibug Saber, M | 1 |
Kim, JW | 1 |
Berry, JL | 1 |
Ma, IH | 1 |
Hu, FR | 1 |
Wang, IJ | 1 |
Chen, WL | 1 |
Hsu, YJ | 1 |
Chu, HS | 1 |
Yuan, CT | 1 |
Hou, YC | 1 |
Santoni, A | 1 |
Thariat, J | 1 |
Maschi, C | 1 |
Herault, J | 1 |
Baillif, S | 1 |
Lassalle, S | 1 |
Peyrichon, ML | 1 |
Salleron, J | 1 |
Caujolle, JP | 1 |
Herwig-Carl, MC | 1 |
Grossniklaus, HE | 2 |
Müller, PL | 1 |
Atzrodt, L | 1 |
Loeffler, KU | 1 |
Dib, S | 1 |
Benhadouch, R | 1 |
Abdou, T | 1 |
Yuksel, D | 1 |
Kosker, M | 1 |
Reddy, JC | 1 |
Celik, T | 1 |
Besley, J | 2 |
Lee, GA | 2 |
Whitehead, K | 1 |
Shah, P | 1 |
Nanji, AA | 1 |
Sayyad, FE | 1 |
Sarici, AM | 1 |
Arvas, S | 1 |
Pazarli, H | 1 |
Lee, JH | 1 |
Kim, YH | 1 |
Kim, MS | 1 |
Kim, EC | 1 |
Kim, BH | 1 |
Kim, MK | 1 |
Wee, WR | 1 |
Oh, JY | 1 |
Pappalardo, J | 1 |
Hirst, LW | 2 |
Vincent, SJ | 1 |
Salazar Méndez, R | 1 |
Baamonde Arbaiza, B | 1 |
de la Roz Martín, P | 1 |
Parra Rodríguez, T | 1 |
de la Cruz Aguiló, RI | 1 |
Duch-Samper, A | 1 |
Hernández Pérez, D | 1 |
Marí Cotino, J | 1 |
Kempin, R | 1 |
Tost, F | 2 |
El Hamichi, S | 1 |
Messaoudi, R | 1 |
Belmalih, M | 1 |
Iferkhass, S | 1 |
Zerrouk, R | 1 |
Reda, K | 1 |
Oubaaz, A | 1 |
Shah, KJ | 1 |
Mogilishetty, G | 1 |
Holland, EJ | 2 |
Vazirani, J | 1 |
Mohapatra, S | 1 |
Hanada, K | 2 |
Nishikawa, N | 2 |
Miyokawa, N | 2 |
Yoshida, A | 2 |
Kusumesh, R | 1 |
Ambastha, A | 1 |
Kumar, S | 1 |
Sinha, BP | 1 |
Imam, N | 1 |
Porubská, K | 1 |
Rohrbach, JM | 1 |
Damato, B | 1 |
Coupland, SE | 1 |
Schallenberg, M | 1 |
Niederdräing, N | 1 |
Rahimi, F | 1 |
Alipour, F | 1 |
Ghazizadeh Hashemi, H | 1 |
Hashemian, MN | 1 |
Mehrdad, R | 1 |
Cunneen, TS | 1 |
Conway, RM | 2 |
Madigan, MC | 1 |
Gentile, CM | 1 |
Burchakchi, AI | 1 |
Oscar, CJ | 1 |
Rudkin, AK | 1 |
Muecke, JS | 1 |
Zimmermann, P | 1 |
Dietrich, T | 1 |
Bock, F | 1 |
Horn, FK | 1 |
Hofmann-Rummelt, C | 1 |
Kruse, FE | 1 |
Cursiefen, C | 1 |
Zaki, AA | 1 |
Farid, SF | 1 |
Evert, M | 1 |
Robinson, L | 1 |
McKellar, M | 1 |
Fitzharris, B | 1 |
Elder, M | 1 |
Grover, S | 1 |
Jacobs, DS | 1 |
Colby, KA | 3 |
Gupta, A | 1 |
Muecke, J | 2 |
Hoyer, A | 1 |
Raiskup, F | 1 |
Pillunat, E | 1 |
Shildkrot, Y | 2 |
Wilson, MW | 4 |
Birkholz, ES | 1 |
Goins, KM | 1 |
Sutphin, JE | 3 |
Kitzmann, AS | 1 |
Wagoner, MD | 1 |
Siddique, SS | 1 |
Gonzalez-Gonzalez, LA | 1 |
Amorese, L | 1 |
Shaikh, M | 1 |
Foster, S | 1 |
Sugandhi, P | 1 |
George, RE | 1 |
Freistuehler, M | 1 |
Anastassiou, G | 1 |
Nareyeck, G | 1 |
Zeschnigk, M | 1 |
Bornfeld, N | 1 |
Scheulen, ME | 1 |
Hilger, RA | 1 |
Cumurcu, T | 1 |
Sener, S | 1 |
Cavdar, M | 1 |
Ditta, LC | 1 |
Shields, CL | 5 |
Ramasubramanian, A | 1 |
Mellen, PL | 1 |
Shields, JA | 5 |
Tokusashi, Y | 1 |
Rodríguez Feijoo, D | 1 |
Romero Moreno, I | 1 |
López Gutierrez, C | 1 |
Usabiaga Usandizaga, M | 1 |
Cisneros Carpio, M | 1 |
Amias Gorostiza, A | 1 |
Alberdi Alberdi, J | 1 |
Oellers, P | 1 |
Kao, AA | 1 |
Abdelaziz, A | 1 |
Feuer, W | 1 |
Dubovy, SR | 1 |
Jain, S | 1 |
Chandravanshi, SL | 1 |
Rathore, MK | 1 |
Goyal, P | 1 |
Jain, SC | 1 |
Tsakalaki, V | 1 |
Halkia, A | 1 |
Haniotis, V | 1 |
Kafousi, M | 1 |
Detorakis, ET | 1 |
Papandroudis, AA | 1 |
Dimitrakos, SA | 1 |
Stangos, NT | 1 |
Yuen, HK | 1 |
Yeung, EF | 1 |
Chan, NR | 1 |
Chi, SC | 1 |
Lam, DS | 1 |
Panda, A | 2 |
Sudan, R | 2 |
Naseripour, M | 2 |
Eagle, RC | 1 |
Rodríguez-Pérez, C | 1 |
Del Campo, Z | 1 |
Wolley-Dod, C | 1 |
Gris, O | 1 |
Bajaj, MS | 1 |
Balasubramanya, R | 1 |
Prakash, G | 1 |
Snyder, ME | 1 |
Sacu, S | 1 |
Ségur-Eltz, N | 1 |
Horvat, R | 1 |
Lukas, JR | 1 |
Zehetmayer, M | 1 |
Groh, MJ | 1 |
Holbach, LM | 1 |
Kühnel, B | 1 |
Naumann, GO | 1 |
Rosner, M | 1 |
Hadar, I | 1 |
Rosen, N | 1 |
Di Pascuale, MA | 1 |
Espana, EM | 1 |
Tseng, SC | 1 |
Dudney, BW | 1 |
Malecha, MA | 1 |
Ramos-López, JF | 1 |
Martínez-Costa Pérez, R | 1 |
Cisneros Lanuza, AL | 1 |
Francés Muñoz, E | 1 |
Monte Boque, E | 1 |
Muñoz Gómez, MC | 1 |
López-Sánchez, EV | 1 |
Menezo Rozalén, JL | 1 |
Kopp, ED | 1 |
Seregard, S | 1 |
Demirci, H | 2 |
Marr, BP | 1 |
Masheyekhi, A | 1 |
Materin, M | 1 |
Stone, DU | 1 |
Butt, AL | 1 |
Chodosh, J | 1 |
Nagel, DS | 1 |
Prabhasawat, P | 1 |
Tarinvorakup, P | 1 |
Tesavibul, N | 1 |
Uiprasertkul, M | 1 |
Kosrirukvongs, P | 1 |
Booranapong, W | 1 |
Srivannaboon, S | 1 |
Kurli, M | 1 |
Finger, PT | 5 |
Becerra, EM | 1 |
Blanco, G | 1 |
Saornil, MA | 1 |
del C Méndez, M | 1 |
Bianciotto, CG | 1 |
Krohn, J | 1 |
Monge, OR | 1 |
Singh, AD | 1 |
Jacques, R | 1 |
Rundle, PA | 1 |
Rennie, IG | 1 |
Mudhar, HS | 1 |
Slater, D | 1 |
Abraham, LM | 1 |
Selva, D | 1 |
Casson, R | 1 |
Leibovitch, I | 1 |
Khong, JJ | 1 |
Tunc, M | 1 |
Erbilen, E | 1 |
Chang, SW | 1 |
Huang, ZL | 1 |
Huerva, V | 2 |
Mateo, AJ | 1 |
Mangues, I | 2 |
Jurjo, C | 1 |
Ozcan, AA | 1 |
Sizmaz, S | 1 |
Yagmur, M | 1 |
Sugiura, M | 1 |
Mihm, MC | 1 |
Zembowicz, A | 1 |
Yu, CS | 1 |
Chiu, SI | 1 |
Ng, CS | 1 |
Chan, HH | 1 |
Tse, RK | 1 |
Pournaras, JA | 1 |
Chamot, L | 1 |
Uffer, S | 1 |
Zografos, L | 1 |
Char, DH | 1 |
Crawford, JB | 1 |
Anandajeya, WV | 1 |
Corrêa, ZM | 1 |
Augsburger, JJ | 1 |
Gericke, A | 1 |
Pitz, S | 1 |
Strempel, I | 1 |
Sekundo, W | 1 |
Milner, MS | 1 |
McCormick, SA | 2 |
Löffler, KU | 1 |
Frucht-Pery, J | 3 |
Sugar, J | 1 |
Baum, J | 1 |
Pe'er, J | 2 |
Savir, H | 1 |
Meisler, DM | 1 |
Foster, JA | 1 |
Folberg, R | 2 |
Rozenman, Y | 3 |
Hungerford, JL | 1 |
George, SM | 1 |
Madreperla, SA | 1 |
Aaberg, TM | 1 |
Heigle, TJ | 1 |
Stulting, RD | 1 |
Palay, DA | 1 |
Gebhardt, DO | 1 |
Czechonska, G | 1 |
Liarikos, S | 1 |
Werschnik, C | 1 |
Lommatzsch, PK | 1 |
Akpek, EK | 1 |
Ertoy, D | 1 |
Kalayci, D | 1 |
Hasiripi, H | 1 |
Haas, K | 1 |
Ben-Dor, D | 1 |
Levartovsky, S | 1 |
Hardten, DR | 1 |
Samuelson, TW | 1 |
Salomão, DR | 1 |
Mathers, WD | 1 |
Cuevas, K | 1 |
Nadjari, B | 2 |
Kersten, A | 2 |
Ross, B | 1 |
Motherby, H | 1 |
Krallmann, R | 1 |
Sundmacher, R | 3 |
Böcking, A | 3 |
Hawkins, AS | 1 |
Yu, J | 1 |
Hamming, NA | 1 |
Rubenstein, JB | 1 |
Schelonka, LP | 1 |
Siegel, D | 1 |
Meininger, A | 1 |
Ross, D | 1 |
Joseph, A | 1 |
Sabri, K | 1 |
Dua, HS | 1 |
Paridaens, D | 1 |
Beekhuis, H | 1 |
van Den Bosch, W | 1 |
Remeyer, L | 1 |
Melles, G | 1 |
Cartsburg, O | 2 |
Pomjanski, N | 2 |
McKelvie, PA | 1 |
Daniell, M | 2 |
Armstrong, T | 1 |
Siganos, CS | 1 |
Kozobolis, VP | 1 |
Christodoulakis, EV | 1 |
Schmidt, M | 1 |
Maier, M | 1 |
Schmidt, T | 1 |
Klaehsen, D | 1 |
Merté, RL | 1 |
Yamamoto, N | 1 |
Ohmura, T | 1 |
Suzuki, H | 1 |
Shirasawa, H | 1 |
Khokhar, S | 1 |
Soni, A | 1 |
SinghSethi, H | 1 |
Sony, P | 1 |
Pangtey, MS | 1 |
Maini, R | 1 |
Tole, D | 1 |
Kallen, C | 1 |
Hillenkamp, J | 1 |
14 reviews available for mitomycin and Conjunctival Neoplasms
Article | Year |
---|---|
Topical pharmacotherapy for ocular surface squamous neoplasia: systematic review and meta-analysis.
Topics: Administration, Topical; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Eye Neoplasms; Fluorourac | 2022 |
Medical treatment for ocular surface squamous neoplasia.
Topics: Carcinoma, Squamous Cell; Conjunctival Neoplasms; Eye Neoplasms; Fluorouracil; Humans; Interferon al | 2023 |
[Diagnosis and Therapy of Benign and Malignant Tumors of the Conjunctiva].
Topics: Adult; Child; Conjunctiva; Conjunctival Neoplasms; Humans; Melanoma; Mitomycin; Neoplasm Recurrence, | 2020 |
[Current Therapies in Superficial Malignant Tumors].
Topics: Conjunctival Neoplasms; Humans; Mitomycin; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Out | 2018 |
Topical chemotherapy for ocular surface squamous neoplasia.
Topics: Administration, Topical; Antimetabolites, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplasms; | 2013 |
[Topical chemotherapy for conjunctival tumours - the medical and legal bearings of the case].
Topics: Administration, Ophthalmic; Antineoplastic Agents; Chemotherapy, Adjuvant; Conjunctival Neoplasms; C | 2014 |
Ocular Surface Squamous Neoplasia in a Living-Related Conjunctival Limbal Allograft.
Topics: Aged; Allografts; Antibiotics, Antineoplastic; Carcinoma in Situ; Combined Modality Therapy; Conjunc | 2016 |
[Topical Mitomycin C as a therapy of conjunctival tumours].
Topics: Administration, Topical; Antibiotics, Antineoplastic; Carcinoma in Situ; Carcinoma, Squamous Cell; C | 2008 |
[Conjunctival tumours in elderly patients].
Topics: Age Factors; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Combined | 2010 |
Treatment of ocular surface squamous neoplasia with Mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in Situ; Chemotherapy, Adjuva | 2010 |
Conjunctival melanoma: pitfalls and dilemmas in management.
Topics: Antibiotics, Antineoplastic; Conjunctival Neoplasms; Cryotherapy; Humans; Lymphatic Metastasis; Mela | 2010 |
Conjunctival melanoma arising from diffuse primary acquired melanosis in a young black woman.
Topics: Administration, Topical; Adult; Antibiotics, Antineoplastic; Black People; Combined Modality Therapy | 2005 |
Mitomycin: clinical applications in ophthalmic practice.
Topics: Antibiotics, Antineoplastic; Cicatrix; Conjunctival Neoplasms; Glaucoma; Humans; Melanoma; Mitomycin | 2006 |
Ocular toxicity of mitomycin-C.
Topics: Antibiotics, Antineoplastic; Conjunctival Neoplasms; Eye; Eye Diseases; Filtering Surgery; Glaucoma; | 1999 |
9 trials available for mitomycin and Conjunctival Neoplasms
Article | Year |
---|---|
Safety and efficacy of topical interferon alpha 2B and mitomycin C for localized conjunctival intraepithelial neoplasia: long-term report of their pharmacological safety and efficacy.
Topics: Administration, Topical; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Conjunc | 2023 |
Treatment of ocular surface squamous neoplasia with Mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in Situ; Chemotherapy, Adjuva | 2010 |
[Management of conjunctival malignant melanoma associated with primary acquired melanosis (PAM) using 0.02% mitomycin C eyedrops].
Topics: Administration, Topical; Antibiotics, Antineoplastic; Conjunctival Neoplasms; Female; Humans; Male; | 2003 |
Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in S | 2007 |
Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in S | 1997 |
Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia.
Topics: Administration, Topical; Adult; Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Conjuncti | 1998 |
Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
Topics: Administration, Topical; Adult; Aged; Antibiotics, Antineoplastic; Atrophy; Chemotherapy, Adjuvant; | 2000 |
Use of mitomycin C in the treatment of corneal conjunctival intraepithelial neoplasia.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in S | 2002 |
Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma.
Topics: Administration, Topical; Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Conjunc | 2002 |
115 other studies available for mitomycin and Conjunctival Neoplasms
Article | Year |
---|---|
Visualizing Ocular Surface Squamous Neoplasia.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; Conjunctival | 2022 |
Advancing wavelike epitheliopathy after conjunctival intraepithelial neoplasia. Atipical case report.
Topics: Administration, Topical; Carcinoma in Situ; Conjunctival Neoplasms; Corneal Diseases; Humans; Mitomy | 2022 |
Supportive treatment to chemotherapy with MMC, in patients with ocular surface squamous neoplasia or conjunctival melanocytic tumor.
Topics: Carcinoma, Squamous Cell; Conjunctival Neoplasms; Eye Neoplasms; Humans; Hyaluronic Acid; Lubricant | 2023 |
Real-life data of adjuvant IFN-α2b and MMC in conjunctival melanocytic lesions.
Topics: Adjuvants, Immunologic; Conjunctival Neoplasms; Humans; Interferon-alpha; Melanosis; Mitomycin; Neop | 2023 |
Current Practice in the Treatment of Epithelial and Melanocytic Tumours with Interferon-α2b: A Survey of Tertiary Eye Centres in Germany.
Topics: Carcinoma, Squamous Cell; Conjunctival Neoplasms; Humans; Interferon-alpha; Mitomycin; Ophthalmic So | 2023 |
Intraoperative mitomycin C and cryotherapy as adjunct therapy for recurrent lobular capillary haemangioma of conjunctiva.
Topics: Adult; Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctival Neoplasms; Cryotherapy; | 2020 |
Clinical Management of Squamous Cell Carcinoma of the Conjunctiva.
Topics: Adult; Ambulatory Surgical Procedures; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Conjun | 2020 |
Extensive conjunctival melanoma successfully treated with surgical resection and pre- and postoperative topical mitomycin C.
Topics: Antibiotics, Antineoplastic; Conjunctival Neoplasms; Humans; Male; Melanoma; Melanosis; Middle Aged; | 2021 |
Primary acquired melanosis/melanoma: utility of conjunctival map biopsy.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Conjunctival Neoplasms; Female; Humans; Melanoma; Melanoma, | 2022 |
Case Series: High-resolution Optical Coherence Tomography as an Optical Biopsy in Ocular Surface Squamous Neoplasia.
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Biopsy; C | 2021 |
Fluorescent in situ hybridization (FISH): A useful diagnostic tool for childhood conjunctival melanoma.
Topics: Child; Conjunctival Neoplasms; Humans; In Situ Hybridization, Fluorescence; Melanoma; Mitomycin; Rar | 2022 |
[Impressive regression of a conjunctival carcinoma with topical mitomycin C].
Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Carcinoma in Situ; Conjunctiva; Conjunct | 2021 |
Giant Ocular Surface Squamous Cell Papilloma Treated With Topical Mitomycin C.
Topics: Administration, Ophthalmic; Aged; Antibiotics, Antineoplastic; Conjunctival Neoplasms; Humans; Male; | 2017 |
Excision and topical 0.04% mitomycin C for extensive and recurrent conjunctival squamous cell carcinoma in an AIDS patient. A case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Co | 2017 |
Mitomycin C or interferon as adjuvant therapy to surgery for ocular surface squamous neoplasia: comparative study.
Topics: Administration, Ophthalmic; Adult; Aged; Aged, 80 and over; Alkylating Agents; Carcinoma in Situ; Ca | 2018 |
Role of topical interferon alpha-2b in 'mitomycin-C-resistant' ocular surface squamous neoplasia: our preliminary findings.
Topics: Administration, Topical; Antineoplastic Agents; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Dr | 2019 |
Resolution of conjunctival melanoma with topical interferon alpha 2b in a patient with mitomycin C intolerance.
Topics: Administration, Ophthalmic; Aged; Antineoplastic Agents; Biomarkers, Tumor; Biopsy; Conjunctival Neo | 2018 |
Extending far and wide: the role of biopsy and staging in the management of ocular surface squamous neoplasia.
Topics: Aged; Antineoplastic Agents; Biopsy; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Corneal Disea | 2019 |
Clinicopathologic correlation of ocular surface squamous neoplasia from a university hospital in North Taiwan 1994 to 2014.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Conjunctival Neopla | 2019 |
Management of Invasive Squamous Cell Carcinomas of the Conjunctiva.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; Conjunctival | 2019 |
Pyogenic granuloma associated with conjunctival epithelial neoplasia: report of nine cases.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma in Situ; Carcino | 2019 |
[Management of squamous cell carcinoma of the conjunctiva in a young patient: Case report].
Topics: Adult; Antineoplastic Agents; Brachytherapy; Carcinoma, Squamous Cell; Combined Modality Therapy; Co | 2019 |
Management of cataracts and oculo-cutaneous malignancy in xeroderma pigmentosum.
Topics: Adolescent; Biological Dressings; Carcinoma, Squamous Cell; Cataract; Conjunctival Neoplasms; Female | 2013 |
Can augmented trabeculectomies cause iatrogenic melanoma?
Topics: Alkylating Agents; Chemotherapy, Adjuvant; Conjunctival Neoplasms; Eye Enucleation; Female; Glaucoma | 2014 |
Combined excision, cryotherapy, and intraoperative mitomycin C (EXCRIM) for localized intraepithelial and squamous cell carcinoma of the conjunctiva.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in Situ; Carcinoma, Squamous | 2013 |
The effect of surgical wide excision and amniotic membrane transplantation with adjuvant topical mitomycin C treatment in recurrent conjunctival--corneal intraepithelial neoplasia.
Topics: Aged; Alkylating Agents; Amnion; Carcinoma in Situ; Combined Modality Therapy; Conjunctival Neoplasm | 2014 |
Clinical and pathological characteristics of ocular surface squamous neoplasia in an Asian population.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Asian People; Carcinoma in Situ; Carcinoma, S | 2013 |
Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc | 2014 |
[Treatment of conjunctival melanoma].
Topics: Aged, 80 and over; Antineoplastic Agents, Alkylating; Biopsy; Chemotherapy, Adjuvant; Combined Modal | 2014 |
Conjunctival intraepithelial neoplasia. Interferon as a rescue therapy after failure of mitomycin C.
Topics: Antineoplastic Agents; Carcinoma in Situ; Conjunctival Neoplasms; Drug Resistance, Neoplasm; Drug Su | 2014 |
Bilateral enucleation avoided by excision with mitomycin C for bilateral infiltrating conjunctival squamous cell carcinoma in a girl with xeroderma pigmentosum.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Child; Combined Modality Therapy; Conjunctival Neop | 2015 |
Ocular Surface Squamous Neoplasia.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Corneal Disease | 2016 |
Long-term outcome of amniotic membrane transplantation combined with mitomycin C for conjunctival reconstruction after ocular surface squamous neoplasia excision.
Topics: Adult; Aged; Aged, 80 and over; Amnion; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Combi | 2017 |
Retrospective Comparative Study of Topical Interferon α2b Versus Mitomycin C for Primary Ocular Surface Squamous Neoplasia.
Topics: Administration, Topical; Alkylating Agents; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Female | 2017 |
[Unclear monocular chronic reddening of the conjunctiva with ptosis].
Topics: Antibiotics, Antineoplastic; Blepharoptosis; Carcinoma in Situ; Conjunctival Neoplasms; Follow-Up St | 2008 |
An audit of conjunctival melanoma treatment in Liverpool.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Brachytherapy; | 2009 |
Topical mitomycin-C for treatment of partially-excised ocular surface squamous neoplasia.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Cornea; | 2009 |
In vitro effects of histone deacetylase inhibitors and mitomycin C on tenon capsule fibroblasts and conjunctival melanoma cells.
Topics: Apoptosis; Butyrates; Cell Cycle; Cell Proliferation; Cell Survival; Conjunctival Neoplasms; Connect | 2009 |
In vivo confocal microscopy study of ocular surface neoplasia manifesting after radial keratotomy and laser in situ keratomileusis.
Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Combined Modality Therapy; Conjunctival Neoplasms; Corn | 2009 |
Mitomycin-C as adjuvant therapy in the treatment of sebaceous gland carcinoma in high-risk locations.
Topics: Adenocarcinoma, Sebaceous; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuv | 2009 |
Tumour-associated lymphangiogenesis in conjunctival malignant melanoma.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Conjunctival Neoplasms; Female; Humans; | 2009 |
Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up.
Topics: Aged; Carcinoma in Situ; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy | 2009 |
Topical mitomycin C for the local treatment of a primary diffuse large B-cell lymphoma of the palpebral conjunctiva.
Topics: Administration, Topical; Adult; Antibiotics, Antineoplastic; Conjunctival Neoplasms; Humans; Lymphom | 2009 |
Boston Ocular Surface Prosthesis for persistent epitheliopathy after treatment of conjunctival melanoma.
Topics: Aged; Alkylating Agents; Artificial Organs; Conjunctival Neoplasms; Corneal Diseases; Epithelium, Co | 2010 |
[Mitomycin C in diffuse multilocal malignant conjunctival melanoma].
Topics: Antibiotics, Antineoplastic; Conjunctival Neoplasms; Humans; Melanoma; Mitomycin; Treatment Outcome | 2010 |
Treatment of ocular surface squamous cell intraepithelial neoplasia with and without mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Biopsy; Carcinoma in Situ; Chemotherapy | 2011 |
Herpes keratitis in a patient undergoing treatment with topical mitomycin C.
Topics: Aged; Antibiotics, Antineoplastic; Antiviral Agents; Carcinoma, Squamous Cell; Conjunctival Neoplasm | 2011 |
Use of combination therapy of topical mitomycin C and cyclosporine a as an adjunct to surgery for corneal and conjunctival intraepithelial neoplasia and invasive squamous cell carcinoma.
Topics: Administration, Topical; Carcinoma in Situ; Carcinoma, Squamous Cell; Combined Modality Therapy; Con | 2011 |
Chemosensitivity of conjunctival melanoma cell lines to chemotherapeutic agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Conjunctival Neoplasms; Humans; Melanoma; Mitomycin; Nitros | 2011 |
Periocular allergic contact dermatitis following topical Mitomycin C eye drop application.
Topics: Administration, Topical; Adrenal Cortex Hormones; Antibiotics, Antineoplastic; Carcinoma, Squamous C | 2011 |
Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mitomycin C: complications and recurrences.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Conjunctival N | 2011 |
Conjunctival squamous cell carcinoma arising in immunosuppressed patients (organ transplant, human immunodeficiency virus infection).
Topics: Adult; Aged; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Female; Graft Rejection; HIV Infectio | 2011 |
Pigmented squamous cell carcinoma in situ of the conjunctiva.
Topics: Amnion; Carcinoma in Situ; Carcinoma, Squamous Cell; Combined Modality Therapy; Conjunctival Neoplas | 2011 |
[Conjunctival keratoacanthoma: diagnosis, treatment and monitoring by conjunctival impression cytology].
Topics: Adult; Carcinoma, Squamous Cell; Combined Modality Therapy; Conjunctival Diseases; Conjunctival Neop | 2012 |
Predictors of ocular surface squamous neoplasia recurrence after excisional surgery.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma in Situ; Carcinoma, Squamous Cell; Conjunctival Neoplasms; | 2012 |
Huge malignant melanoma of caruncle with extensive involvement of conjunctiva.
Topics: Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctival Neoplasms; Cryotherapy; Humans; | 2012 |
Conjunctival seborrheic keratosis manifesting as squamous carcinoma.
Topics: Alkylating Agents; Carcinoma, Squamous Cell; Conjunctival Diseases; Conjunctival Neoplasms; Diagnosi | 2013 |
Mitomycin C therapy for conjunctival-corneal intraepithelial neoplasia.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplasms; Corneal Diseases; Eye | 2002 |
The use of postoperative topical mitomycin C in the treatment of recurrent conjunctival papilloma.
Topics: Adult; Antibiotics, Antineoplastic; Conjunctiva; Conjunctival Neoplasms; Humans; Male; Mitomycin; Ne | 2002 |
Comment on intraoperative use of mitomycin C in excision of ocular surface neoplasia with or without limbal autograft transplantation.
Topics: Antibiotics, Antineoplastic; Carcinoma in Situ; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Co | 2002 |
Topical mitomycin-C for pagetoid invasion of the conjunctiva by eyelid sebaceous gland carcinoma.
Topics: Adenocarcinoma, Sebaceous; Administration, Topical; Aged; Aged, 80 and over; Antibiotics, Antineopla | 2002 |
[Topical treatment with mitomycin C in considerably raised conjunctival intraepithelial neoplasia].
Topics: Administration, Topical; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in Situ; Co | 2002 |
Topical mitomycin C for conjunctival-corneal squamous cell carcinoma.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Conjunctival Neoplas | 2003 |
Conjunctival intraepithelial neoplasia.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Carcinoma in | 2003 |
Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Cataract; Cataract Extraction; Conjunctival Ne | 2003 |
Successful treatment with mitomycin C eye drops for conjunctival diffuse intraepithelial neoplasia with sebaceous features.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplasms; Female; Humans; Mitomy | 2003 |
A case of conjunctiva-cornea intraepithelial neoplasia successfully treated with topical mitomycin C and interferon alfa-2b in cycles.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma in Situ; Conj | 2004 |
Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in Situ; Co | 2004 |
[Treatment of conjunctival intraepithelial neoplasia with topical mitomycin C 0.02%].
Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplasm | 2004 |
Epiphora as a side effect of topical mitomycin C.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Conjunctival N | 2004 |
Chemoreduction with topical mitomycin C prior to resection of extensive squamous cell carcinoma of the conjunctiva.
Topics: Administration, Topical; Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Conjunc | 2005 |
Ocular surface squamous neoplasia: a standard of care survey.
Topics: Administration, Topical; Antineoplastic Agents; Biopsy; Combined Modality Therapy; Conjunctival Neop | 2005 |
Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma.
Topics: Administration, Topical; Adult; Aged; Antibiotics, Antineoplastic; Carcinoma in Situ; Carcinoma, Squ | 2005 |
Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Conjunctival N | 2005 |
Hughes technique, amniotic membrane allograft, and topical chemotherapy in conjunctival melanoma with eyelid involvement.
Topics: Administration, Topical; Amnion; Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctiva | 2005 |
[Conjunctival primary acquired melanosis].
Topics: Aged; Antibiotics, Antineoplastic; Conjunctival Diseases; Conjunctival Neoplasms; Cryotherapy; Diagn | 2005 |
Neoadjuvant topical mitomycin C chemotherapy for conjunctival and corneal intraepithelial neoplasia.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplasms; Cornea; Humans; Male; | 2006 |
Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia.
Topics: Adenocarcinoma, Sebaceous; Antibiotics, Antineoplastic; Carcinoma in Situ; Carcinoma, Squamous Cell; | 2006 |
Topical mitomycin chemotherapy for malignant conjunctival and corneal neoplasia.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Conjunctival Neoplasms; Corneal Diseases; Drug | 2006 |
Topical cyclosporine-a combined with mitomycin C for conjunctival and corneal squamous cell carcinoma.
Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Conjunctival N | 2006 |
Oral cimetidine adjuvant therapy for recalcitrant, diffuse conjunctival papillomatosis.
Topics: Administration, Oral; Alkylating Agents; Child; Cimetidine; Combined Modality Therapy; Conjunctival | 2006 |
Short-term mitomycin C followed by long-term interferon alpha2beta for conjunctiva-cornea intraepithelial neoplasia.
Topics: Administration, Topical; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; | 2006 |
Topical mitomycin C for the treatment of conjunctival tumor.
Topics: Administration, Topical; Adult; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in Situ; C | 2007 |
Low-risk and high-risk histologic features in conjunctival primary acquired melanosis with atypia: Clinicopathologic analysis of 29 cases.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Cell Nucleolus; Cell Nucleus; Chemother | 2007 |
Localized conjunctival mucosa-associated lymphoid tissue (MALT) lymphoma is amenable to local chemotherapy.
Topics: Administration, Topical; Adult; Antibiotics, Antineoplastic; Biopsy; Conjunctival Neoplasms; Female; | 2008 |
Conjunctival intraepithelial neoplasia in a patient treated with tacrolimus after liver transplantation.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma in Situ; Combined Modality Therapy; Conjunctival Neopla | 2007 |
Orbital invasion despite topical anti-metabolite therapy for conjunctival carcinoma.
Topics: Administration, Topical; Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Con | 2008 |
Treatment of conjunctival squamous neoplasias with interferon alpha 2ab.
Topics: Administration, Topical; Antineoplastic Agents; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Fl | 2008 |
Primary acquired melanosis with atypia treated with mitomycin C.
Topics: Alkylating Agents; Conjunctival Diseases; Conjunctival Neoplasms; Cryosurgery; Humans; Male; Melanom | 2009 |
[Bilateral ocular surface squamous neoplasia and neurodermatitis. Two cases with different courses].
Topics: Adult; Antibiotics, Antineoplastic; Biological Dressings; Carcinoma, Squamous Cell; Chemotherapy, Ad | 2008 |
Topical chemotherapy for conjunctival melanoma.
Topics: Administration, Topical; Conjunctiva; Conjunctival Neoplasms; Female; Humans; Melanoma; Middle Aged; | 1993 |
[Mitomycin as local therapeutic drug in ocular neoplasms].
Topics: Antibiotics, Antineoplastic; Conjunctival Neoplasms; Corneal Diseases; Eye Neoplasms; Follow-Up Stud | 1997 |
Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplas | 1997 |
Mitomycin C treatment of conjunctival intraepithelial neoplasia.
Topics: Antibiotics, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplasms; Humans; Mitomycin; Ophthalmi | 1997 |
Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in Situ; Co | 1997 |
Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplasms; Cor | 1998 |
[Mitomycin C in treatment of conjunctival melanoma and primary acquired melanosis].
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Combined Modality Ther | 1998 |
Postoperative topical mitomycin C in conjunctival squamous cell neoplasia.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Conjunctival Ne | 1999 |
Treatment of conjunctival corneal intraepithelial neoplasia with topical mitomycin C.
Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplasm | 1999 |
Cytologic changes in the conjunctiva mimicking malignancy after topical mitomycin C chemotherapy.
Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Biopsy; Cell Nucleus; Conjunctiva; Conju | 1999 |
Cytologic and DNA cytometric diagnosis and therapy monitoring of squamous cell carcinoma in situ and malignant melanoma of the cornea and conjunctiva.
Topics: Aneuploidy; Antibiotics, Antineoplastic; Carcinoma in Situ; Carcinoma, Squamous Cell; Conjunctival N | 1999 |
Treatment of recurrent conjunctival papillomatosis with mitomycin C.
Topics: Antibiotics, Antineoplastic; Child, Preschool; Conjunctival Neoplasms; Female; Humans; Mitomycin; Ne | 1999 |
Treatment of conjunctival intraepithelial neoplasia with topical drops of mitomycin C.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplasms; Diagnosis, Diff | 2000 |
Immunohistochemical localization of NQO1 in epithelial dysplasia and neoplasia and in donor eyes.
Topics: Antibodies, Monoclonal; Carcinoma in Situ; Carcinoma, Squamous Cell; Conjunctiva; Conjunctival Neopl | 2000 |
Surgical excision, autolimbal transplantation, and mitomycin C in the treatment of conjunctival and corneal intraepithelial neoplasia.
Topics: Adult; Carcinoma in Situ; Combined Modality Therapy; Conjunctival Neoplasms; Corneal Diseases; Corne | 2001 |
Amniotic membrane transplantation in the management of conjunctival malignant melanoma and primary acquired melanosis with atypia.
Topics: Administration, Topical; Aged; Amnion; Conjunctival Neoplasms; Corneal Transplantation; Female; Huma | 2001 |
[Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control].
Topics: Adult; Aged; Carcinoma in Situ; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality | 2001 |
Impression cytology following mitomycin C therapy for ocular surface squamous neoplasia.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Apoptosis; Carcinoma, Squamous Cell; Conjunctival Neoplasm | 2001 |
Management of conjunctival and corneal melanoma with surgical excision, amniotic membrane allograft, and topical chemotherapy.
Topics: Adult; Amnion; Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctival Neoplasms; Corne | 2001 |
The intraoperative use of mitomycin-C in excision of ocular surface neoplasia with or without limbal autograft transplantation.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in Situ; Carcinoma, Squamous Cell; C | 2002 |
[The treatment of a primary acquired melanosis of the conjunctiva with atypia by low dose of Mitomycin C 0.02 % - case report with follow up of 2 years].
Topics: Administration, Topical; Aged; Biopsy; Cell Transformation, Neoplastic; Conjunctiva; Conjunctival Ne | 2001 |
Successful treatment with 5-fluorouracil of conjunctival intraepithelial neoplasia refractive to mitomycin-C.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Carcinoma in Situ; Conjunctival Neopla | 2002 |
Combined surgery, cryotherapy, and mitomycin-C for recurrent ocular surface squamous neoplasia.
Topics: Adult; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; Conjunctiva | 2002 |
Topical mitomycin-C for partially excised conjunctival squamous cell carcinoma.
Topics: Administration, Topical; Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Conjunc | 2002 |
Topical mitomycin C and radiation induce conjunctival DNA-polyploidy.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Biopsy; Carcinoma, Squamous Cell; Combined Modality Therap | 2001 |